The largest database of trusted experimental protocols

Diclofenac

Manufactured by Novartis
Sourced in Germany, India, Italy

Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) used in the pharmaceutical industry for research and development purposes. It is a synthetic compound that exhibits anti-inflammatory, analgesic, and antipyretic properties.

Automatically generated - may contain errors

8 protocols using diclofenac

1

Evaluation of a Polyherbal Formulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Diclofenac was obtained from Novartis Pharma, Egypt; Omeprazole from Eipico, Egypt; STW 5 (Iberogast®) was generously supplied by Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany. STW 5 consists of a combination of standardized fixed proportions of hydro-alcoholic extracts of the following medicinal herbs Iberis amara, Melissa officinalis, Matricaria recutita, Carum carvi, Mentha piperita, Angelica archangelica, Silybum marianum, Chelidonium majus and Glycyrrhiza glabra. The other chemicals used were all of analytical grade.
+ Open protocol
+ Expand
2

In Vivo Lmnb1 Silencing by Electroporation

Check if the same lab product or an alternative is used in the 5 most similar protocols

Lmnb1 silencing in vivo was carried out by in utero electroporation using Lmnb1 shRNA (Sh-Lmnb1) or scramble-shRNA (Sh-Scr) plasmids as described35 (link). The pregnant female C57BL6/J mouse (E14) was anesthetized using isofluorane. After injection of DNA (3 µg) containing 1% Fast-Green dye (Sigma) through the uterine wall into the lumen of the telencephalic vesicles, each embryo was subjected to electroporation by five square electric pulses (30 mV for 50 ms, 1 s intervals) delivered through platinum electrodes (Sonidel) using a BTX-ECM 830 electroporator (Harvard Apparatus). After electroporation, the abdominal cavity was sutured and the pregnant mouse was administered diclofenac (0.5 mg/kg) (Voltaren, Novartis) by intraperitoneal injection and kept warm until awake. For Lmnb1 knockdown studies, electroporated pups were born and immediately transferred to a foster CD-1 mother. The pups were sacrificed at postnatal day 7 (P7) and the brains collected for analysis.
+ Open protocol
+ Expand
3

TPA-Induced Ear Edema Model in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ear edema test model induced by 12-O-tetradeca-noylphorbol-13-acetate (TPA) (Sigma-Aldrich, Saint Louis, MO, USA) was used [48 ]. TPA was dissolved in ethanol (2.5 µg/20 mL), and the solvent did not interfere with the assay. The experimental animals were randomly assigned into three groups: TPA (only positive control), TPA plus diclofenac (Novartis, Mexico City) (nonsteroidal anti-inflammatory drug, negative control) and TPA plus ChEEP. The left ears of the mice were not treated and were the control in each organism. The animals were fasted for 4 h prior to the experiment. Subsequently, they were anesthetized with 250 µL of isoflurane (PISA, Mexico City, Mexico) (inhalation anesthetic), and 10 µL of TPA was administered topically to the inner and outer surface of the right ear of each group. Thirty minutes after the application of TPA, animals received 10 µL of diclofenac or 10 mg of ChEEP on both sides of the right ear. Mice were sacrificed by cervical dislocation after 4 h, and a circular punch biopsy (5 mm) of the right and left ears was taken and fixed in formalin. The histological evaluation included H&E staining and ear thickness was measured with the ImageJ program. Inflammation was assessed by the increase in thickness of the right ear compared to that of the left ear of each of the experimental organisms.
+ Open protocol
+ Expand
4

Diosmin Versus Mannitol-Dexamethasone for Radicular Pain

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three hundred outpatients with radicular pain were randomly assigned into the Diosmin group and the active-control, that is, mannitol and dexamethasone [10 (link)], group with 1 : 1 ratio using computer-aided random assignment. Diosmin group received Diosmin (Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.) per os, 900 mg, tid for 2 weeks followed by bid for 2 weeks, and lastly 450 mg bid as maintenance dose for at least one month [11 , 12 ]. Control group received 20% mannitol (CR Double-Crane Pharmaceuticals Co., Ltd.) 250 ml (1 g/kg/day) and dexamethasone (Furuitang Pharmaceutical Co., Ltd.) 10 mg/day intravenously guttae for the first 3 days and followed by mannitol for 4 days. In both groups, the courses of treatment lasted at least one month. The patients with serious pain [visual analog scale (VAS) > 8 in our study] were given diclofenac (Novartis) 75 mg/day for maximum 7 days. In case symptoms appeared again one month after last symptoms disappeared, the same regimen was given again.
+ Open protocol
+ Expand
5

Evaluation of LPN Capsule and Diclofenac

Check if the same lab product or an alternative is used in the 5 most similar protocols
LPN capsule (5 mg, India-Mart, India), diclofenac (voltaren 15 mg/ml, ampoule, Novartis, India), and other chemicals were purchased from a private pharmaceutical company (Dar-Al-Dwa, Iraq).
+ Open protocol
+ Expand
6

Diclofenac and Antioxidant Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
diclofenac (diclofenac K; Novartis, Cairo, Egypt) was dissolved in distilled water to a concentration that would assure that a rat would receive per os a dose of 5 mg diclofenac/kg body weight. In these studies, the single diclofenac treatment occurred alone or in combination with (i.e., 2 hr after the final of the 7 daily doses) the test antioxidants. α-Lipoic acid (α-LA; EVA Pharma, Giza, Egypt; in normal saline) was delivered by intraperitoneal injection at a dose of 50 mg α-LA/kg [3 (link)]. Each daily per os delivery of sodium selenite (Sigma, St. Louis, MO; in water) at 2.5 mg sodium selenite/kg [4 (link)]; Vit C (ADWIC, Al Qalyubiyah, Egypt; in water) at 1 g/kg [5 (link)], Vit E (MP Biomedicals, Bas-Rhin, France; in olive oil) at 300 mg/kg [6 (link)], and zinc sulfate (ADWIC; in water) at 25 mg ZnSO4/kg [7 (link)] was performed without anesthesia and with a delivery volume of 1 mL/rat. The diclofenac volume (alone or after the final antioxidant dosing) was 1 mL/rat as well.
+ Open protocol
+ Expand
7

Evaluation of Nutmeg Oil for Inflammatory Relief

Check if the same lab product or an alternative is used in the 5 most similar protocols
The complete Freund's adjuvant (CFA) was purchased from Sigma (F5881, Sigma-Aldrich, USA). Diclofenac was purchased from Novartis, Beijing. The nutmeg oil and Gas chromatography–mass spectrometry (GC–MS) results of nutmeg oil were kindly provided by the Functional Oil Laboratory Associated by Oil Crops Research Institute, Chinese Academy of Agricultural Sciences and Infinite Co., LTD., Guangzhou 510000, China. 2% tween-20 was used for emulsification of nutmeg oils and diluted before the application. All other reagents were purchased from Sigma-Aldrich, USA.
+ Open protocol
+ Expand
8

Pharmacological Modulation of Autism-Like Behaviors

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 14 days from OA induction, CTR and MIA mice were divided into three experimental groups (n = 14/each) and started the treatment with either drugs or vehicle. In detail, both CTR and MIA mice were treated with vehicle (saline solution, 10 µL/g), with the non-peptidic antagonist of the PK system PC1 (s.c., 150 µg/kg, twice a day) [37 (link),42 (link),43 (link)] or with the NSAID diclofenac (i.p., 10 mg/kg, once a day, Novartis, Milan, Italy) [44 (link)]. All drugs were freshly prepared, and each treatment was daily (once/twice) administered for 14 days (from day 14 until day 27). Mice were sacrificed the day after the last drug administration (day 28).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!